Company:  ENZO BIOCHEM INC (ENZ)
Form Type:  10-K
Filing Date:  10/12/2021 
CIK:  0000316253 
Address:  60 EXECUTIVE BLVD 
City, State, Zip:  FARMINGDALE, New York 11735 
Telephone:  (516) 755-5500 
Fiscal Year:  07/31 
Last Trade
Last Trade: 
$2.42  
Change: 
-0.06 (-2.42%)  
Trade Time: 
04:10 PM EST  
Market Cap: 
$117.88M
Trade ENZ now with 

© 2022  
Description of Business
Enzo Biochem, Inc. (the "Company" "we", "our" or "Enzo") is an integrated diagnostics, clinical lab, and life sciences company focused on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable our customers to meet their clinical needs. Through a connection with the market, we provide advanced biotechnology solutions to the global community as affordable and flexible quality products and services. We develop, manufacture and sell our proprietary technology solutions and platforms to clinical laboratories, specialty clinics, researchers and physicians globally. Enzo's structure and business strategy represent the culmination of years of extensive planning and work. The Company has the unique ability to offer low cost, high performance products and services for diagnostic testing, which ideally positions us to capitalize on the reimbursement pressures facing diagnostic labs.
Register and access this filing in:     
  FORM 10-K
    PART I
      Item 1. Business
      Item 1A. Risk Factors
      Item 1B. Unresolved Staff Comments
      Item 2. Properties
      Item 3. Legal Proceedings
      Item 4. Mine Safety Disclosures
    Part II
      Item 5. Market for Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data
      Item 9. Changes in and Disagreements with Accountants on ...
      Item 9A. Controls and Procedures
      Item 9B. Other Information
    PART III
      Item 10. Directors, Executive Officers and Corporate Governance
      Item 11. Executive Compensation
      Item 12. Security Ownership of Certain Beneficial Owners and ...
      Item 13. Certain Relationships and Related Transactions, and ...
      Item 14. Principal Accountant Fees and Services
    PART IV
      Item 15. Exhibits, Financial Statement Schedules
    SIGNATURES
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    CASH FLOW
    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      BALANCE SHEET
      INCOME STATEMENT
    VALUATION AND QUALIFYING ACCOUNTS
  EXHIBIT 21
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 31.A
    CERTIFICATIONS
  EXHIBIT 31.B
    CERTIFICATIONS
  EXHIBIT 32.A
    CERTIFICATE PURSUANT TO
  EXHIBIT 32.B
    CERTIFICATE PURSUANT TO